ONO-4059
Showing 1 - 25 of 96
Part A: Relapsed or Refractory Primary CNS Lymphoma (PCNSL), Part B: Newly Diagnosed, Treatment naïve PCNSL Trial in United
Recruiting
- Part A: Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL), Part B: Newly Diagnosed, Treatment naïve PCNSL
-
Duarte, California
- +29 more
Jun 15, 2022
Non Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia Trial in France, United Kingdom (Tirabrutinib)
Completed
- Non Hodgkins Lymphoma
- Chronic Lymphocytic Leukaemia
-
Lille, France
- +5 more
Feb 22, 2021
Chronic Lymphocytic Leukemia Trial in Germany (Tirabrutinib, Entospletinib, Obinutuzumab)
Completed
- Chronic Lymphocytic Leukemia
- Tirabrutinib
- +2 more
-
Aschaffenburg, Germany
- +14 more
Dec 17, 2021
Relapsed/Refractory B-cell Malignancies Trial in France, United Kingdom (Tirabrutinib)
Completed
- Relapsed/Refractory B-cell Malignancies
-
Lille, Nord, France
- +5 more
Mar 23, 2022
Rheumatoid Arthritis Trial in United States (Tirabrutinib, Placebo)
Multiple System Atrophy (MSA) Trial in Fountain Valley (ONO-2808, Placebo)
Not yet recruiting
- Multiple System Atrophy (MSA)
- ONO-2808
- Placebo
-
Fountain Valley, CaliforniaThe Parkinson's Movement and Disorder Institute
Jun 20, 2023
Relapsed or Refractory T Cell Lymphoma Trial in United States (ONO-4685)
Recruiting
- Relapsed or Refractory T Cell Lymphoma
-
Birmingham, Alabama
- +10 more
Sep 20, 2022
Advanced or Metastatic Solid Tumors Trial in Tokyo (ONO-7475, ONO-7475 + ONO-4538)
Suspended
- Advanced or Metastatic Solid Tumors
- ONO-7475
- ONO-7475 + ONO-4538
-
Tokyo, JapanTokyo Clinical Site
Dec 19, 2021
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial (ONO-7018)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
- (no location specified)
Aug 23, 2022
Neurodegenerative Diseases Trial in London (ONO-2808, Placebo)
Completed
- Neurodegenerative Diseases
- ONO-2808
- Placebo
-
London, United KingdomParexel International Early Phase Clinical Unit (EPCU)
Dec 10, 2021
Healthy Volunteers Trial in Hakata (ONO-4685, Placebo, KLH)
Completed
- Healthy Volunteers
- ONO-4685
- +4 more
-
Hakata, Fukuoka, JapanFukuoka Clinical Site
Nov 9, 2021
Gastric Cancer Trial in Worldwide (Nivolumab, Tegafur-gimeracil-oteracil potassium, Oxaliplatin)
Active, not recruiting
- Gastric Cancer
- Nivolumab
- +4 more
-
Anhui Province, China
- +107 more
May 22, 2022
Advanced Solid Tumors, Recurrent Solid Tumors Trial in Seongnam-si, Seoul (ONO-4538)
Completed
- Advanced Solid Tumors
- Recurrent Solid Tumors
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +4 more
Nov 16, 2021
Solid Tumor Trial in Chuo-ku (ONO-7913)
Active, not recruiting
- Solid Tumor
- ONO-7913
-
Chuo-ku, Tokyo, JapanLocal Institution
May 5, 2021
Advanced NSCLC Trial in Korea, Republic of (ONO-4538)
Completed
- Advanced Non-small Cell Lung Cancer
-
Cheongju-si, Chungcheongbuk-do, Korea, Republic of
- +9 more
Mar 19, 2021